CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Half Yearly Report and Accounts, page-3

  1. 5,939 Posts.
    lightbulb Created with Sketch. 414
    Made contact with Leighton Mills again regarding company’s thoughts on the losses. He made some good points about cannabis company’s all heading south and the general market sentiment. Agree with him the company has been good on the cash burn and there’s still 4 mil in the bank , but the only nearest chance of revenue raising via the topical cream they’re developing is looking like end of this year at best.
    Long term I still believe in Cannpal, but short term over the course of this year , don’t be surprised to see SP slide even further unfortunately. 

 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.